» Articles » PMID: 33532152

The Prevalence and Association of Depression and Anxiety With Multiple Sclerosis in Riyadh, Saudi Arabia: A Cross-Sectional Study

Overview
Journal Cureus
Date 2021 Feb 3
PMID 33532152
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction Multiple sclerosis (MS) is often associated with depression and anxiety, with no clear prevalence, and the relationship between them is not fully understood. Methods In a cross-sectional study of 365 multiple sclerosis patients selected through a random sampling method from the MS society of Riyadh, Saudi Arabia, we collected data by self-administered questionnaires - the Patient Health Questionnaire (PHQ-9) and the Generalized Anxiety Disorder (GAD-7) questionnaire - and analyzed by descriptive and analytical statistics. Results Approximately 51.1% of participants had moderate or severe anxiety and 64% of them had depression among community-based multiple sclerosis patients according to Generalized Anxiety Disorder (GAD-7) questionnaire, and according to the PHQ-9 Arabic version about 28.85% showed mild to moderate depression. The MS patients aged 53 to over 60 years showed higher levels of mild anxiety (76.32%) and higher levels of depression ranging from mild to moderate (53.61%) (P = 0.001). While the MS patients younger than 53 years showed moderate to severe anxiety (60.71%) and depression levels (62.32%). In different age group bad health status (37.6%) was associated with a higher prevalence of depression levels (P =< 0.001) and people who were widowed (22.38%), divorced (26%), and separated (37.82%) had significant depression levels (P = 0.017). In terms of anxiety, 54.58% of females had anxiety (P = 0.005), more older people showed anxiety (43.17%) (P = 0.026), and people with a bad general health state (26.38%) had anxiety (P = <0.001). Conclusion Among different types of MS patients, anxiety is more prevalent in the elder group (76%) of people and depression is more prevalent in young patients (62%).

Citing Articles

Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab.

Craner M, Al Malik Y, Babtain F, Alshamrani F, Alkhawajah M, Alfugham N Neurol Ther. 2022; 11(4):1457-1473.

PMID: 36048334 PMC: 9434517. DOI: 10.1007/s40120-022-00401-4.


Prevalence of depression and anxiety among adult patients with multiple sclerosis at Riyadh City, Saudi Arabia.

Alharbi N, Alawi S, Alharbi Y, Alharbi M, Alsamarh T, Aldubaiyan A Neurosciences (Riyadh). 2022; 27(2):71-78.

PMID: 35477919 PMC: 9257915. DOI: 10.17712/nsj.2022.2.20210101.


Prevalence of Anxiety and Depression in Patients With Multiple Sclerosis in Saudi Arabia: A Cross-Sectional Study.

Aljishi R, Almatrafi R, Alzayer Z, Alkhamis B, Yaseen E, Alkhotani A Cureus. 2022; 13(12):e20792.

PMID: 34993046 PMC: 8720031. DOI: 10.7759/cureus.20792.

References
1.
Patrick S, Connick P . Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: A systematic review. PLoS One. 2019; 14(2):e0197943. PMC: 6380554. DOI: 10.1371/journal.pone.0197943. View

2.
Algahtani H, Shirah B, AlZahrani F, Abobaker H, Alghanaim N, Manlangit Jr J . Quality of life among multiple sclerosis patients in Saudi Arabia. Neurosciences (Riyadh). 2017; 22(4):261-266. PMC: 5946374. DOI: 10.17712/nsj.2017.4.20170273. View

3.
AlZahrani A, AlShamrani F, Al-Khamis F, Al-Sulaiman A, Al Ghamdi W, Al Ghamdi O . Association of acute stress with multiple sclerosis onset and relapse in Saudi Arabia. Saudi Med J. 2019; 40(4):372-378. PMC: 6506663. DOI: 10.15537/smj.2019.4.24010. View

4.
Alsaadi T, El Hammasi K, Shahrour T, Shakra M, Turkawi L, Mudhafar A . Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study. Mult Scler Int. 2015; 2015:487159. PMC: 4512603. DOI: 10.1155/2015/487159. View

5.
Haussleiter I, Brune M, Juckel G . Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment. Ther Adv Neurol Disord. 2010; 2(1):13-29. PMC: 3002616. DOI: 10.1177/1756285608100325. View